InsidersTradesSigma
Explore the detailed record of transactions filed by Dorman H. Paul, Director. Insider active across 1 company, notably Phio Pharmaceuticals Corp.. In total, 1 reports have been published. History available since 15 February 2022. The latest transaction was filed on 15 February 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Dorman H. Paul is a Director at Phio Pharmaceuticals Corp. In this role, he contributes to the governance of the company and strategic decision-making. Paul brings valuable expertise in biopharmaceuticals, thereby supporting Phio's growth objectives. His experience as a director is crucial in ensuring transparency and accountability within the organization.